Skip to content

Effects of bupivacaine liposome used for quadratus lumborum muscle block on the quality of recovery and gastrointestinal barrier function in elderly patients undergoing colorectal cancer surgery

Effects of bupivacaine liposome used for quadratus lumborum muscle block on the quality of recovery and gastrointestinal barrier function in elderly patients undergoing colorectal cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118207
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-02-05
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

experimental group:Bilateral quadratus lumborum blocks were performed under ultrasound guidance before the induction of general anesthesia, with 20 mL of liposomal bupivacaine (133 mg diluted in norma
control group:Bilateral quadratus lumborum blocks were performed under ultrasound guidance before the induction of general anesthesia, with 20 mL of 0.375% ropivacaine administered on each side. Gener

Sponsors

Changzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 In line with the clinical diagnosis of primary colorectal cancer; 2 American Society of Anesthesiologists (ASA) Physical Status Classification Class I-III. 3 Meet the indications for radical resection of colorectal cancer and undergo laparoscopic radical resection of colorectal cancer; 4 Good cognitive function and basic communication skills; 5 Age >= 65 years old; 6 Patients and family members sign informed consent.

Exclusion criteria

Exclusion criteria: 1 Toxic shock, polytrauma, or adrenal insufficiency; 2 History of psychiatric disorders; 3 Severe hepatic or renal dysfunction such as liver fibrosis or uremia; 4 Coexisting other malignant tumors; 5 Coagulation abnormalities; 6 Previous history of abdominal surgery; 7 Infection at the puncture site; 8 Coexisting other gastrointestinal diseases; 9 History of allergy to the anesthetic agents used in this study.

Design outcomes

Primary

MeasureTime frame
Time of first anal exhaust after surgery;Time of first anal defecation after surgery;I-FEED score;

Secondary

MeasureTime frame
heart rate;mean arterial pressure;Intraoperative blood loss;Postoperative recovery time;extubation time;duration of PACU stay;Numeric Rating Scale;PCA press count within 72 hours postoperatively;Total Opioid Consumption;Diamine Oxidase (DAO);D-lactate;Operation duration;Total postoperative hospital stay;

Countries

China

Contacts

Public ContactHu'ting'ting

Changzhou First People's Hospital

16605191872@163.com+86 151 8978 1872

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026